The largest database of trusted experimental protocols

40 protocols using synergy 4 hybrid microplate reader

1

Emodin Cytotoxicity and Sorbitol Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
FHL 124 cells (104 cells) were grown in 96-well plates for the cell viability assay or 105 cells in 60 mm dishes for the sorbitol colorimetric assay. For the viability assay, cells were treated with the indicated concentrations of emodin. After a 24 h treatment, 10 μL of MTT (5 mg mL−1 in PBS) was added to 100 μL of culture medium/well for 4 h, and the cell viability was determined by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma-Aldrich) as described.65 (link) Levels of MTT were determined by measuring the absorbance at 570 nm by using a BioTek Synergy 4 Hybrid microplate reader (BioTek, Winooski, VT, USA). For sorbitol colorimetric assays, cells were treated with emodin and low or high glucose, followed by washing with cold PBS twice. In lens organ culture, lenses were homogenized using RIPA buffer. The cell lysates were followed by deproteinization with a deproteinizing sample preparation kit (BioVision, Milpitas, CA, USA). Sorbitol determinations with neutralized samples were carried out using a D-sorbitol colorimetric assay kit (BioVision) and a BioTek Synergy 4 Hybrid microplate reader for measuring analyte absorbance at 560 nm.
+ Open protocol
+ Expand
2

Biochemical Profiling of AKT Isoforms

Check if the same lab product or an alternative is used in the 5 most similar protocols
Biochemical analysis was performed using kinases obtained from Millipore (AKT1, ∆AKT1, ∆AKT2, ∆AKT3) and Signal Chem (AKT2 and AKT3). The specific activity of AKT 1,2 and 3 was determined to be 114 nmol/min/mg, 44 nmol/min/mg and 200 nmol/min/mg respectively as per activity assay protocol. ALM301 was profiled using the Fluorescent Polarisation (FP) iMAP Screening Express kit (Molecular Devices) using the FAM-Crosstide substrate [5FAM-GRPRTSSFAEG-OH] (Molecular Devices) against the three isoforms of AKT and their PH domain null mutants. Compounds were dissolved in DMSO prior to screening at 14 point titration series in the range (50 µM–50 pM). Fluorescence polarisation was measured using a Biotek Synergy 4 Hybrid microplate reader. Percentage inhibition of kinase activity was calculated and IC50 values derived using non-linear regression on GraphPad Prism. Competition of ALM301 with ATP was determined using AKT1 under increasing ATP concentrations up to 1000 µM.
+ Open protocol
+ Expand
3

Quantifying ATP Release from Cochlear Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
The P5 mouse temporal bone was micro-dissected in ice-cold HBSS (Thermo Fisher Scientific). The inner ear was opened from its apex to base. After removal of the bone, the exposed BM and SV were dissected separately and put into an incubation chamber. For testing ATP release, the isolated BM and SV was incubated in a zero Ca2+ solution (ZCS) containing (in mM): 137 NaCl, 5.36 KCl, 0.44 KH2PO4, 0.18 Na2HPO4, 0.1 EGTA, 25 HEPES, and 5.55 Dextrose (pH 7.3). To quantify ATP release, the BM and SV were incubated in ZCS for 20 min at 37°C, 5% CO2. The collected incubation solutions were kept on ice. The amount of ATP was measured by a bioluminescence method with a luciferin-luciferase assay kit (FL-ASC, Sigma, USA) using a black 96-well plate to avoid optical cross-talk. The bioluminescence was read by a Biotek Synergy 4 Hybrid Microplate Reader (Biotek Instruments Inc, Winooski, VT, USA). All bioluminescence measurements reported in this article fell within the linearity range of the ATP standard curve generated according to the manufacturer’s instructions.
+ Open protocol
+ Expand
4

Quantifying Macrophage and RMG Cytokine Secretion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Macrophages (105 cells) or RMG (103 cells) were incubated in a 24-well or 96-well plate and media were collected after AGA or hypoxia treatment. Secreted TNF-α and VEGF in media were determined using corresponding Mouse TNF-α DuoSet ELISA Development kit (R&D Systems, Inc., Minneapolis, MN, USA) and Mouse VEGF DuoSet kit (R&D Systems, Inc.). The optical density was detected using a BioTek Synergy 4 Hybrid Microplate Reader (Bio Tek, Winooski, VT, USA) and the level of cytokine was deduced from the absorbance value by extrapolation from a standard curve generated in parallel.
+ Open protocol
+ Expand
5

Quantifying Serum TNF-α Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
The concentration of serum TNF-α was determined by an ELISA kit (70-EK282/3-96, Multi Sciences Biotech Co. Ltd., Hangzhou, China) following the instruction manual. A microplate reader (Synergy 4 Hybrid Microplate Reader, BioTek, Vermont, USA) was used to measure the optical density spectrophotometrically at 450 and 630 nm.
+ Open protocol
+ Expand
6

Cytotoxicity of Doxorubicin-Peptide Conjugate

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HeLa and MCF-7 cancer cells were seeded in a 96-well plate with the density of 10,000 cells per-well (total medium volume of 100 μL). 24 hours post seeding, the solutions with a serial of concentrations of doxorubicin-peptide mixture or free doxorubicin in 100 μL of medium were added to each well (five wells for each concentration). Cells without the treatment of the compounds were used as the control. The MTT assays were performed after an extra culture time of 24 hours. All compounds were removed and 90 μL of fresh medium was added for each well, 10 μL of MTT solution (5 mg/mL) was added and incubated for 4 hours in 37°C. Pipette out the spent media, formazon crystals at the bottom of each well were dissolved in 100 μL DMSO. After 15 minutes shaking at room temperature, absorbance at wavelength of 490 nm was tested using a BioTek Synergy™ 4 Hybrid Microplate Reader. The experiment was repeated for 3 times. IC50 values for the inhibition of cell viability were calculated from pharmacological inhibitory response curves using software Prism 5.0.
+ Open protocol
+ Expand
7

Intracellular ROS Assessment using CM-H2DCFDA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The assessment of intracellular ROS was done using fluorescent probe, CM-H2DCFDA (Invitrogen). NS-SV-AC cells were detached and resuspended in medium at 2 × 105 cells/ ml. Five ml of cell suspension was incubated with 5 M CM-H2DCFDA for 30 minutes at 37 °C in CO2 incubator. Cells were centrifuged and unincorporated probe was washed out. Cell suspension was irradiated (8 Gy), or not, before plating 2 × 104 cells/ well in 96 well plates. GA was added 30 minutes later, and fluorescence was analyzed using Synergy 4 Hybrid Microplate Reader (Biotek) at indicated times.
+ Open protocol
+ Expand
8

Screening for TLK1B Kinase Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Compounds from the NIH Clinical Collection, the Prestwick Chemical Library, the ChemDiv Library, and the Enzo Life Sciences Redox Library were screened for modulators of TLK1B. Bacterially isolated recombinant protein TLK1B was reacted with its phosphorylation substrate, Rad9, in Kinase Assay buffer (ADP-Hunter Plus Assay, Discoverx). The ADP generated during the kinase reaction was measured by the formation of florescent Resorufin, at 590 nM using Synergy 4 Hybrid Microplate Reader (Biotek).
+ Open protocol
+ Expand
9

Characterization of Self-Assembled Nanofibers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The synthesized compounds were characterized using 1H NMR (Bruker ARX 400). LC-MS spectrometric analyses were performed at the LCMS-20AD (Shimadzu) system. HPLC was conducted at LUMTECH HPLC (Germany) system using a C18 RP column with MeOH (0.05% of TFA) and water (0.05% of TFA) as the eluents. Rheology was performed on an AR 2000ex (TA instrument) system using a parallel plates (40 mm) at the gap of 500 μm. MTT data was recorded on a BioTek Synergy™ 4 Hybrid Microplate Reader. TEM images were done on a Tecnai G2 F20 system, operating at 200 kV. The zeta potentials of the self-assembled nanofibers were measured by a zeta potential analyzer (Zeta Pals, Brookhaven Instruments, Huntsville, NY, USA). Before measurements, the hydrogels formed by adding different equiv. of doxorubicin to the 0.5 wt% peptide solution and peptide solution itself were all diluted for 5 times by 1 × PBS, affording corresponding nanofiber solutions. The zeta potential was then measured with palladium electrodes at 25°C, and the mean value of three readings was taken.
+ Open protocol
+ Expand
10

Redox Modulation of Cytokine Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded onto a black 96-well plate (BrandTech Scientific, CAT# 91-425TB) at 25,000 cells per well in 100 µL of medium. The following day, the plate was exposed in triplicate to increasing doses of TNFα (50 pg/mL to 5 ng/mL), butyrate (50 µM to 7.5 mM), as well as co-treatment of 500 µM butyrate and TNFα (50 pg/mL–5 ng/mL) by adding 100 µL of 2× chemical stocks. Next, 50 µM menadione was added 4 h prior to the 24 h time period and served as a positive control for ROS production. After 24 h of incubation, 100 µL was removed. A 40 µM H2DCFDA dye solution (2×) was prepared and vortexed. Next, 100 µL of this mixture was added to each well using a multichannel pipette. The plate was mixed at 400 rpm via orbital shaker; then, it was incubated in 5% CO2 at 37 °C for 45 min. Fluorescence was measured at an ex/em of 485/535 nm on a BioTek Synergy™ 4 Hybrid Microplate Reader using the autogain feature. The data represent the combination of two technical replicates normalized to the medium control (n = 3 wells/technical replicate for experimental conditions).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!